Device Surgical Care

Adept

Payments companies reported to CMS as associated with Adept. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$77Kassociated payments (2023-2025)
236clinicians with associated payments
1company reporting

By year

2023 $9,377
2024 $45K
2025 $22K

Payments reported as associated with Adept, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $42K
Obstetrics & Gynecology $25K
Physician Assistant $1,423
Gynecologic Oncology $1,225
Surgery $862
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) $809

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Adept

These are the largest totals companies reported as associated with Adept. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mona Orady San Francisco, CA Obstetrics & Gynecology $12,905.93
Ahmet Kilic Columbus, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $8,075.00
Yuji Kawano Boston, MA Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,843.45
Michael Robich Greeley, CO Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,530.00
David Caparrelli Manchester, NH Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,530.00
David Zapata Lawrenceville, GA Thoracic Surgery (Cardiothoracic Vascular Surgery) $5,910.00
Bradley Taylor Boca Raton, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $5,360.00
Michael Stine Tampa, FL Obstetrics & Gynecology $4,693.14
Jessica Stine New Port Richey, FL Gynecologic Oncology $406.22
Jose Rodriguez Tampa, FL Obstetrics & Gynecology $290.46

Prescribed Adept?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.